Kintayl Capital’s Sotera Health SHC Stock Holding History

Kintayl Capital’s Portfolio SHC Stock Details SHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-419,796	Closed	-$4.89M	–	48
2025 Q1	$4.89M	Sell	419,796 -410,792	-49%	-$5.29M	3.46%	11
2024 Q4	$11.4M	Buy	+830,588	New	+$12M	10.49%	1

Other funds holding SHC

Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

DCP

Darsana Capital Partners New York $4.7B AUM 50.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

SHCM

Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Kintayl Capital's SHC Position: Q2 2025 in Review

Kintayl Capital sold out of Sotera Health (SHC) in Q2 2025, closing a stake of 419,796 shares — an estimated $4.89M sold.

Kintayl Capital first reported a position in SHC in Q4 2024 and held it in 2 quarters. The position peaked at $11.4M in Q4 2024. 223 funds tracked by Wall St. Rank hold SHC as of Q2 2025.

Kintayl Capital reported no remaining Sotera Health position as of Q2 2025 after selling out during the quarter.
Kintayl Capital sold 419,796 Sotera Health shares in Q2 2025, an estimated $4.89M.
Kintayl Capital first reported a position in Sotera Health in Q4 2024 and held it in 2 quarters.
Kintayl Capital's Sotera Health position peaked at $11.4M in Q4 2024.
223 funds tracked by Wall St. Rank held Sotera Health as of Q2 2025.

Based on Kintayl Capital's 13F filing for Q2 2025, filed 14 Aug 2025.